Latent TB Infection and Active TB Disease
Latent TB infection occurs when individuals are infected with Mycobacterium tuberculosis but do not show symptoms. They are not infectious and cannot spread the disease. However, without treatment, latent infection can progress to active TB disease, particularly when the immune system weakens. Active TB disease manifests with symptoms and poses a risk of transmission to others.
Latent TB infection (LTBI) occurs when individuals harbor the TB bacteria without symptoms of active disease. LTBI is diagnosed through tuberculin skin tests or blood tests and is not contagious. However, LTBI can progress to active TB disease, especially in those with weakened immune systems. Active TB disease presents with symptoms like cough, fever, and weight loss, and is contagious through respiratory droplets. Diagnosis involves sputum analysis, chest X-rays, and molecular tests. Treatment for LTBI aims to prevent progression to active disease, while active TB disease is treated with a combination of antibiotics for several months to prevent transmission and complications.
Related Conference of Latent TB Infection and Active TB Disease
16th International Conference on Pulmonary & Respiratory Medicine
18th International Conference on Chronic Obstructive Pulmonary Disease
Latent TB Infection and Active TB Disease Conference Speakers
Recommended Sessions
- Cardiopulmonary Disease
- Chronic Obstructive Pulmonary Disease (COPD)
- Climate Change and Respiratory Diseases
- Drug-Resistant Tuberculosis:
- Early Detection and Diagnosis
- Epidemiology of TB Disease
- Gastroesophageal reflux disease (GERD)
- Infection Control Measures
- Integrated Healthcare Approach
- Latent TB Infection and Active TB Disease
- Lung Cancer: Screening, Diagnosis & Treatment
- Lung Function in Men with and without HIV
- Lung Infection
- Multidrug-resistant TB
- Mycobacterial Infections
- Nutrition and Tuberculosis
- One Health Approach to TB Control
- Palliative Care for Advanced Lung Cancer
- Pediatric Tuberculosis
- Preventive Therapy
- Pulmonary Complications of Endocrine Diseases
- Pulmonary Diseases and Therapeutics
- Pulmonary Edema
- Research and Innovation
- TB Clinical Trials
- TB Vaccines
- TB-HIV Co-Infection:
- TB-HIV Co-infections
- Tuberculosis in Vulnerable Populations
- Vaccination Programs:
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- AI in Respiratory Care - COPD SUMMIT 2026 (Italy)
- Air Pollution & Tobacco Control - COPD SUMMIT 2026 (Italy)
- Asthma COPD Overlap (ACO) - COPD SUMMIT 2026 (Italy)
- Asthma: New Insights & Therapies - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Airway Techniques - COPD SUMMIT 2026 (Italy)
- COPD & Cardiovascular Diseases - COPD SUMMIT 2026 (Italy)
- COPD Diagnosis & Guidelines - COPD SUMMIT 2026 (Italy)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis - COPD SUMMIT 2026 (Italy)
- COPD Pharmacotherapy - COPD SUMMIT 2026 (Italy)
- COPD Prevention & Self-Management - COPD SUMMIT 2026 (Italy)
- COPD: Advances & Management - COPD SUMMIT 2026 (Italy)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - COPD SUMMIT 2026 (Italy)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Cancer: Diagnosis & Treatment - COPD SUMMIT 2026 (Italy)
- Lung Fibrosis - COPD SUMMIT 2026 (Italy)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Next-Gen COPD Treatments - COPD SUMMIT 2026 (Italy)
- Non-Invasive Ventilation (NIV) - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pediatric Respiratory Care - COPD SUMMIT 2026 (Italy)
- Personalized Pulmonary Medicine - COPD SUMMIT 2026 (Italy)
- Pneumonia & Tuberculosis - COPD SUMMIT 2026 (Italy)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - COPD SUMMIT 2026 (Italy)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Apnea - COPD SUMMIT 2026 (Italy)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
